Aerosol Delivery Efficiency With High-Flow Nasal Cannula Therapy in Neonatal, Pediatric, and Adult Nasal Upper-Airway and Lung Models.
Robert M DiBlasiRebecca J EngbergJonathan PoliKristen E CarlinNiko KontoudiosP Worth LongestMasaki Kajimoto
Published in: Respiratory care (2024)
The inhaled lung dose was low (1-5%) during HFNC. Approaches that streamline aerosol delivery are needed to provide safe and effective therapy to patients receiving aerosolized medications with this HFNC system.